# Neurodawn Pharmaceutical Co., Ltd.

Organization · id `cardio:org-neurodawn-pharmaceutical-co-ltd` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov sponsor names](<https://clinicaltrials.gov/search?spons=Neurodawn+Pharmaceutical+Co.%2C+Ltd.>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 7 trials in this atlas.

## Technical summary

Sponsor class industry. No ROR record matches the name exactly.

## The registry's words

- Sponsor name: Neurodawn Pharmaceutical Co., Ltd.
- Sponsor class: INDUSTRY

## Connected pages

- Sponsors: Efficacy and Safety of Minocycline in Patients With Moderate to Severe Acute Ischemic Stroke (`cardio:ct-nct05836740`)
- Sponsors: Efficacy and Safety of Sarecycline in Patients With Acute Ischemic Stroke After Reperfusion Therapy (`cardio:ct-nct05836753`)
- Sponsors: Cilostazol Dexborneol Versus Placebo for Microcirculation Dysfunction After Reperfusion Therapy in Patients With Acute Ischemic Stroke With Large Vessel Occlusion (`cardio:ct-nct05836766`)
- Sponsors: EFfects of Y-6 SUblingual Tablets foR PaTients With AcUte Ischemic StRokE (FUTURE) (`cardio:ct-nct06138834`)
- Sponsors: Y-3 Injection in the Treatment of Acute Ischemic Stroke Phase II Clinical Trial (`cardio:ct-nct06429384`)
- Sponsors: Y-3 for Injection in the Treatment of Acute Ischemic Stroke (`cardio:ct-nct06517173`)
- Sponsors: Y-6 Sublingual Tablets for Patients With Acute Ischemic Stroke (`cardio:ct-nct07040085`)

## Provenance

Content hash: 37180a1d1867d920eebeee0a65c55d4d83be46056833768820f22b7233e3e1b7
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
